Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Caliper and Seegene Partner to Provide Innovative Multiplex Molecular Diagnostics Products

Published: Tuesday, January 18, 2011
Last Updated: Tuesday, January 18, 2011
Bookmark and Share
Caliper and Seegene partner to deliver innovative diagnostic panels on Caliper's LabChip® Dx platform.

Caliper Life Sciences, Inc. and Seegene, Inc. have announced that they have entered into a strategic partnership to enable Seegene's SeePlex™ multiplex diagnostic assays to run on Caliper's innovative LabChip® Dx platform. The SeePlex assays will be marketed and distributed outside of the United States in a preferred partnership for use with the LabChip Dx through Seegene's extensive network of global distributors.

The parties will co-market Caliper's LabChip Dx platform and Seegene's complete line of multiplex diagnostic content effective immediately, and work together to implement specific content and platform technology development efforts to expand the number of diagnostic tests available, which will be offered in a unique, co-branded product brochure. Seegene and Caliper intend to work together to commercialize selected diagnostic assays with improved sensitivity and specificity while reducing overall costs.

The LabChip Dx system, which includes specific diagnostic identification, scoring and reporting software, developed in collaboration with Seegene, is based on the same approach that has become the standard, microfluidic based, electrophoretic separation platform in life sciences research, enabling high throughput, multiplex, cost effective sample processing for discovery and validation of molecular and companion diagnostics.

The platform can analyze large numbers of multiplex samples using very minimal volume of sample with automatic pipetting and avoids the need to further purify or dilute diagnostic PCR products. The cost-effective approach of Caliper's robust microfluidics technology explains its high rate of adoption among research laboratories around the world.

Seegene's proprietary technologies and products have been shown in roughly 500 publications and posters to deliver more accurate and cost effective results in diagnostic testing, a huge benefit for clinical testing laboratories, where accuracy and speed are critical.

Seegene's Dual Priming Oligonucleotide (DPO) approach to PCR-based assays uses a new technique for DNA priming which is structurally and functionally different from traditional PCR priming. Seegene has successfully validated a wide variety of assays utilizing DPO technology in various markets around the world.

"Caliper continues to develop innovative microfluidic solutions that uniquely enable molecular and companion diagnostics," said Kevin Hrusovsky, President and CEO of Caliper Life Sciences. "This agreement to partner with Seegene's innovative multiplex diagnostic content on the LabChip Dx platform should dramatically improve the economics of diagnostic testing and pave the way for the development of critical diagnostics to accelerate the worldwide implementation of personalized medicine. We believe that Seegene's DPO technology uniquely enables sensitive and specific, highly multiplexed assays directly from clinical samples, significantly improving the economics of today for centralized and hospital based diagnostic testing."

"We are pleased to partner with Caliper for developing new and highly innovative molecular and companion diagnostic products," said Jong-Yoon Chun, Seegene Founder and CEO. "Our unique SeePlex technology enables highly multiplexed PCR directly from clinical samples. When coupled with Caliper's microfludics based electrophoretic LabChip platforms, the SeePlex assays enable new paradigms for a variety of analytes in a fully automated and highly cost effective manner. We believe our partnership to commercialize on Caliper's LabChip Dx platform should provide the most competitive and cost effective approach to diagnosing and managing a variety of threats to public health, thus contributing to the improvement of worldwide health."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Caliper Life Sciences and IntegenX Enter License Agreement for Microfluidics Patent Portfolio
IntegenX and Caliper Life Sciences announced a license agreement providing IntegenX access to Caliper's microfluidics patent portfolio.
Friday, March 11, 2011
Caliper Life Sciences Introduces High Throughput RNA Assay for Gene Expression Studies
According to Company, the new assay assures integrity of RNA samples and offers improved throughput and walk-away time.
Thursday, September 13, 2007
Caliper Life Sciences Licenses Monogram Biosciences' Microfluidics Patents
Additional intellectual property portfolio to expand and strengthen Caliper Driven™ licensing program.
Thursday, May 03, 2007
Caliper Life Sciences Closes Multiple LabChip and IVIS Sales at Top Pharma and Biotech Companies
Pfizer, AstraZeneca and Momenta Pharmaceuticals purchase Caliper systems for In Vitro and In Vivo research efforts.
Wednesday, December 13, 2006
Caliper Continues Momentum with Expanded LabChip 3000 Sales
Currently 12 of the top 15 pharmaceutical companies actively use Caliper systems as key tools in their discovery efforts.
Friday, May 26, 2006
Caliper Life Sciences Aids the Sanger Institute's Protein Expression Project
The Wellcome Trust Sanger Institute has purchased the microfluidic-based LabChip® 90 Automated Electrophoresis System to quality control DNA and proteins.
Wednesday, April 05, 2006
Caliper Strengthens Distribution Channels in China, Hong Kong and India
Leading international distributors expand customer access to Caliper microfluidics and drug discovery technologies.
Monday, February 13, 2006
Caliper Completes Acquisition of NovaScreen
The acquisition combines NovaScreen's screening, profiling and assay development services with Caliper's LabChip® and liquid handling products.
Thursday, October 06, 2005
QIAGEN and Agilent to Co-Market Lab-on-a-Chip Solutions

Thursday, March 27, 2003
Caliper Technologies expands Caliper 250 system

Monday, March 10, 2003
Caliper rejects LB Acquisitions

Thursday, February 13, 2003
Caliper cut's Amphora Discovery's purchase obligations

Tuesday, December 17, 2002
Caliper Technologies Payment From 2001 Litigation Settlement

Wednesday, October 16, 2002
Caliper's executive reorganisation plan

Tuesday, May 14, 2002
Caliper sues Molecular Devices

Wednesday, April 17, 2002
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
New Device Could Improve Cancer Detection
UBC researchers develop a microfluidic device to capture circulating tumor cells.
Gut Model HuMiX Works Like the Real Thing
Developed by scientists at the Luxembourg Centre for Systems Biology, the “Human Microbial Cross-talk” model is representative of the actual conditions and processes that occur within our intestines.
'Kidney on a Chip' Facilitates Safer Drug Dosing
University of Michigan researchers have used a "kidney on a chip" device to mimic the flow of medication through human kidneys and measure its effect on kidney cells.
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Lab-on-a-Chip for Detecting Glucose
By integrating microfluidic chips with fiber optic biosensors, researchers in China are creating ultrasensitive lab-on-a-chip devices to detect glucose levels.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!